Zhengye Biotechnology Holding Ltd. Insider Trading

ZYBT

Zhengye Biotechnology Holding Ltd.'s insiders don't report trades to the SEC

Insider trades on this page come from SEC Form 4 filings. ZYBT is a company from outside the US, so its directors report their trades to the market regulator in its home country instead, and there are no Form 4 filings to show. This is the case for most companies listed outside the US, and for foreign companies with US-listed shares.

See what insiders are buying in US companies

Open-market buys by executives and directors, from today's SEC filings.

Insider buys

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with ZYBT

CompareIntrinsic value

MAK.XETRMaternus-Kliniken Aktiengesellschaft

€0.86-2.84%61

CONTX.XOSLContextVision AB

kr 4.43-2.64%36

AZT.XOSLArcticZymes Technologies ASA

€2.05+1.99%23

MDXHMDxHealth SA

$0.16-1.01%30

REG1V.XHELRevenio Group Oyj

€10.32+0.10%51

SEZI.XSTOSenzime AB

€0.28+2.02%40

GENO.XSTOGenovis AB

€1.88+0.32%53

TALEA.XMILTalea Group S.p.A.

No recent price33

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZYBT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.